CRIS Current Research Information System

MORIGI, ALICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.698
AS - Asia 1.787
NA - Nord America 1.586
Continente sconosciuto - Info sul continente non disponibili 100
AF - Africa 94
SA - Sud America 78
OC - Oceania 4
Totale 7.347
Salva come PNG Salva come JPEG
Nazione #
NL - Olanda 2.020
US - Stati Uniti d'America 1.551
VN - Vietnam 627
DE - Germania 527
IT - Italia 496
SG - Singapore 423
CN - Cina 338
SE - Svezia 187
HK - Hong Kong 158
GB - Regno Unito 116
FR - Francia 77
RU - Federazione Russa 70
IN - India 58
BR - Brasile 52
IE - Irlanda 41
FI - Finlandia 40
UA - Ucraina 38
KR - Corea 30
JP - Giappone 29
TG - Togo 28
JO - Giordania 24
CI - Costa d'Avorio 23
CA - Canada 22
NG - Nigeria 18
AR - Argentina 14
ID - Indonesia 14
PL - Polonia 14
ZA - Sudafrica 14
BE - Belgio 13
TH - Thailandia 13
BD - Bangladesh 12
TR - Turchia 12
AT - Austria 11
ES - Italia 11
MX - Messico 8
PH - Filippine 7
TW - Taiwan 7
BG - Bulgaria 6
EE - Estonia 6
SA - Arabia Saudita 6
SC - Seychelles 6
CL - Cile 5
IQ - Iraq 5
AU - Australia 4
MY - Malesia 4
RO - Romania 4
RS - Serbia 4
UZ - Uzbekistan 4
DK - Danimarca 3
LT - Lituania 3
PT - Portogallo 3
CO - Colombia 2
EC - Ecuador 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
MK - Macedonia 2
OM - Oman 2
PK - Pakistan 2
PS - Palestinian Territory 2
QA - Qatar 2
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
Totale 7.248
Salva come PNG Salva come JPEG
Città #
Eygelshoven 1.286
Kerkrade 666
Frankfurt am Main 355
Singapore 310
Ashburn 205
Hong Kong 146
Chandler 141
Ho Chi Minh City 138
Santa Clara 123
San Jose 117
Fairfield 95
Dong Ket 93
Hanoi 93
Southend 87
Bologna 73
Milan 56
Beijing 48
Hefei 45
Houston 44
Princeton 44
Rome 44
Dublin 41
Los Angeles 37
Seattle 37
Boardman 36
Council Bluffs 36
Helsinki 33
Kyiv 31
Falkenstein 30
Berlin 29
Lomé 28
Lauterbourg 27
Wilmington 27
Da Nang 26
New York 26
Woodbridge 26
Amman 24
Seoul 24
Abidjan 23
Cambridge 23
Ann Arbor 22
Tokyo 21
Bremen 16
Abeokuta 15
Catania 14
Haiphong 14
Chicago 13
Redmond 13
Secaucus 13
Brussels 12
Buffalo 11
Düsseldorf 11
Turin 11
Warsaw 11
Columbus 10
Nanjing 10
São Paulo 10
Westminster 10
Guangzhou 9
Jinan 9
Shenyang 9
Toronto 9
Des Moines 8
Florence 8
Istanbul 8
Jakarta 8
Olalla 8
Bangkok 7
Dallas 7
Hưng Yên 7
Lappeenranta 7
London 7
Nuremberg 7
Ottawa 7
San Diego 7
Verona 7
Zhengzhou 7
Amsterdam 6
Bengaluru 6
Brooklyn 6
Bến Tre 6
Changsha 6
Jiaxing 6
Modena 6
Orem 6
Quận Bình Thạnh 6
Vienna 6
Hangzhou 5
Hyderabad 5
Hải Dương 5
Jeddah 5
Nha Trang 5
Padova 5
Parma 5
Quận Một 5
Redwood City 5
Reggio Emilia 5
Saint Petersburg 5
Shanghai 5
Thái Nguyên 5
Totale 5.281
Salva come PNG Salva come JPEG
Nome #
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years 2.875
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience 471
Design of New Personalized Therapeutic Approaches for Diffuse Large B-Cell Lymphoma through Gut Microbiome Profiling 244
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study 228
The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience 224
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone Lymphoma 217
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients 217
Long-term responders after Brentuximab vedotin: Single-center experience on relapsed and refractory hodgkin lymphoma and anaplastic large cell lymphoma patients 208
The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients 203
PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series 195
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma 181
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies 177
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma 168
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients 168
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia 167
Granulomatous tattoo reaction in a nivolumab-treated patient 166
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience 159
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 158
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience 151
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series 126
Long-term efficacy and safety of ibrutinib in the treatment of CLL patients: A real life experience 125
Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma 123
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 115
Spontaneous remission of follicular lymphoma 111
Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation 91
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report 79
Totale 7.347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.260
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022399 0 11 16 43 30 18 3 36 13 57 106 66
2022/2023645 46 100 49 85 54 43 14 61 99 16 40 38
2023/2024277 19 40 27 35 27 29 12 19 9 26 10 24
2024/20251.126 69 104 83 74 169 80 104 54 27 108 52 202
2025/20264.075 159 194 114 131 163 1.398 1.230 45 400 129 58 54
2026/2027116 50 66 0 0 0 0 0 0 0 0 0 0
Totale 7.347